Dr Lei (Stanley) Qi

Dr. Lei Qi (Stanley) is an Assistant Professor of Bioengineering and of Chemical and Systems Biology in Stanford University, USA. He is one of the major contributors to the development the CRISPR technologies for sequence-specific genome regulation, as well as live-cell genome imaging. He invented a number of technologies, including CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), CRISPR imaging, and high-throughput gain-of-function or loss-of-function screening. His current lab focuses on developing new technologies relevant to genome engineering, and applying these technologies to the study of stem cell fate determination and cancer immunotherapy. He obtained his Ph.D. in Bioengineering from the University of California, Berkeley, and worked as Systems Biology Faculty Fellow in the University of California, San Francisco. He joined Stanford Bioengineering in 2014. He obtained a number of awards including the NIH Director’s Early Independence Award.